BioCentury
ARTICLE | Clinical News

Androgen-DHT: UMED began a Phase II trial

April 15, 1996 7:00 AM UTC

Unimed Pharmaceuticals Inc. (UMED), Buffalo Grove, Ill. Product: Androgen-DHT, dihydrotestosterone gel Indication: Geriatric hypogonadism Status: UMED began a Phase II trial of Androgen-DHT, the activ...